Clinical Trial Update: Top-down Infliximab Study in Kids With Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for top-down infliximab in pediatric Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED